The GLCC is the international 'voice' of lung cancer patients.
Established in 2001, the GLCC comprises 35 non-government patient organisations from Argentina, Australia, Brazil, Bulgaria, Canada, Denmark, Egypt, France, Germany, Ireland, Israel, Italy, Japan, Mexico, Netherlands, Norway, Portugal, Russia, Slovenia, Spain, Sweden, Switzerland, UK and US.
The GLCC is committed to improving disease outcomes for all lung cancer patients and aims to address the following issues:
- place lung cancer on the global healthcare agenda
- change public perceptions and lessen the stigma of lung cancer
- empower lung cancer patients to take an active role in their care
- effect change in legislative or regulatory policies to optimise treatment and care